AAAAAA

   
Results: 1-9 |
Results: 9
IN-VITRO ACTIVITIES OF RIFABUTIN, AZITHROMYCIN, CIPROFLOXACIN, CLARITHROMYCIN, CLOFAZIMINE, ETHAMBUTOL, AND AMIKACIN IN COMBINATIONS OF 2, 3, AND 4 DRUGS AGAINST MYCOBACTERIUM-AVIUM
Authors: YAJKO DM SANDERS CA MADEJ JJ CAWTHON VL HADLEY WK
Citation: Dm. Yajko et al., IN-VITRO ACTIVITIES OF RIFABUTIN, AZITHROMYCIN, CIPROFLOXACIN, CLARITHROMYCIN, CLOFAZIMINE, ETHAMBUTOL, AND AMIKACIN IN COMBINATIONS OF 2, 3, AND 4 DRUGS AGAINST MYCOBACTERIUM-AVIUM, Antimicrobial agents and chemotherapy, 40(3), 1996, pp. 743-749
CLINICAL UTILITY OF A COMMERCIAL TEST BASED ON THE POLYMERASE CHAIN-REACTION FOR DETECTING MYCOBACTERIUM-TUBERCULOSIS IN RESPIRATORY SPECIMENS
Authors: CHIN DP YAJKO DM HADLEY WK SANDERS CA NASSOS PS MADEJ JJ HOPEWELL PC
Citation: Dp. Chin et al., CLINICAL UTILITY OF A COMMERCIAL TEST BASED ON THE POLYMERASE CHAIN-REACTION FOR DETECTING MYCOBACTERIUM-TUBERCULOSIS IN RESPIRATORY SPECIMENS, American journal of respiratory and critical care medicine, 151(6), 1995, pp. 1872-1877
PREDICTIVE VALUE OF ACID-FAST SMEARS OF SPUTUM OBTAINED BY EXPECTORATION VERSUS INDUCTION OR BRONCHOALVEOLAR LAVAGE IN PATIENTS WITH TUBERCULOSIS - REPLY
Authors: YAJKO DM NASSOS PS SANDERS CA MADEJ J HADLEY WK
Citation: Dm. Yajko et al., PREDICTIVE VALUE OF ACID-FAST SMEARS OF SPUTUM OBTAINED BY EXPECTORATION VERSUS INDUCTION OR BRONCHOALVEOLAR LAVAGE IN PATIENTS WITH TUBERCULOSIS - REPLY, Clinical infectious diseases, 20(6), 1995, pp. 1575-1576
OUTCOMES MEASUREMENT - THE KEY TO THE APPROPRIATE USE OF PHARMACEUTICALS
Authors: GREY RR TOWNSEND RJ SANDERS CA
Citation: Rr. Grey et al., OUTCOMES MEASUREMENT - THE KEY TO THE APPROPRIATE USE OF PHARMACEUTICALS, International journal of technology assessment in health care, 11(3), 1995, pp. 472-484
COLORIMETRIC METHOD FOR DETERMINING MICS OF ANTIMICROBIAL AGENTS FOR MYCOBACTERIUM-TUBERCULOSIS
Authors: YAJKO DM MADEJ JJ LANCASTER MV SANDERS CA CAWTHON VL GEE B BABST A HADLEY WK
Citation: Dm. Yajko et al., COLORIMETRIC METHOD FOR DETERMINING MICS OF ANTIMICROBIAL AGENTS FOR MYCOBACTERIUM-TUBERCULOSIS, Journal of clinical microbiology, 33(9), 1995, pp. 2324-2327
INDUSTRYS EFFORTS - DEVICES AND PHARMACEUTICALS
Authors: SANDERS CA
Citation: Ca. Sanders, INDUSTRYS EFFORTS - DEVICES AND PHARMACEUTICALS, The Annals of thoracic surgery, 60(5), 1995, pp. 1537-1540
HIGH PREDICTIVE VALUE OF THE ACID-FAST SMEAR FOR MYCOBACTERIUM-TUBERCULOSIS DESPITE THE HIGH PREVALENCE OF MYCOBACTERIUM-AVIUM COMPLEX IN RESPIRATORY SPECIMENS
Authors: YAJKO DM NASSOS PS SANDERS CA MADEJ JJ HADLEY WK
Citation: Dm. Yajko et al., HIGH PREDICTIVE VALUE OF THE ACID-FAST SMEAR FOR MYCOBACTERIUM-TUBERCULOSIS DESPITE THE HIGH PREVALENCE OF MYCOBACTERIUM-AVIUM COMPLEX IN RESPIRATORY SPECIMENS, Clinical infectious diseases, 19(2), 1994, pp. 334-336
RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF RIFAMPIN, ETHAMBUTOL, AND CIPROFLOXACIN FOR AIDS PATIENTS WITH DISSEMINATED MYCOBACTERIUM-AVIUM COMPLEX INFECTION
Authors: JACOBSON MA YAJKO D NORTHFELT D CHARLEBOIS E GARY D BROSGART C SANDERS CA HADLEY WK
Citation: Ma. Jacobson et al., RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF RIFAMPIN, ETHAMBUTOL, AND CIPROFLOXACIN FOR AIDS PATIENTS WITH DISSEMINATED MYCOBACTERIUM-AVIUM COMPLEX INFECTION, The Journal of infectious diseases, 168(1), 1993, pp. 112-119
THE ORPHAN DRUG-ACT - SHOULD IT BE CHANGED
Authors: SANDERS CA
Citation: Ca. Sanders, THE ORPHAN DRUG-ACT - SHOULD IT BE CHANGED, Archives of internal medicine, 153(23), 1993, pp. 2623-2625
Risultati: 1-9 |